Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Ironwood Pharmaceuticals (IRWD) Shares Repurchased (2022)

Ironwood Pharmaceuticals (IRWD) has disclosed Shares Repurchased for 1 consecutive years, with $33.9 million as the latest value for Q2 2022.

  • Quarterly Shares Repurchased changed N/A to $33.9 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $126.4 million through Dec 2022, changed N/A year-over-year, with the annual reading at $126.4 million for FY2022, 423.78% up from the prior year.
  • Shares Repurchased hit $33.9 million in Q2 2022 for Ironwood Pharmaceuticals, down from $92.5 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $92.5 million in Q1 2022 to a low of $33.9 million in Q2 2022.